3,4-dihydroxyphenylacetic acid has been researched along with uric acid in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 12 (60.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraini, JH; Fechtali, T; Rostain, JC | 1 |
| Beal, MF; Matson, WR; Miller, JM; Uemura, Y | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, E; Miele, M | 1 |
| Marsden, CA; Sharp, T; Ungerstedt, U; Zetterström, T | 1 |
| Bierer, DW; Quebbemann, AJ | 1 |
| Fumero, B; Gonzalez-Mora, JL; Guadalupe, T; Mas, M; Mora, F; O'Neill, RD; Valladares, F | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, E; Miele, M; Migheli, R | 1 |
| De Natale, G; Desole, MS; Esposito, G; Fresu, L; Miele, E; Miele, M; Migheli, R | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Grella, G; Miele, E; Miele, M | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, E; Miele, M; Mura, MA | 1 |
| Cano, J; Machado, A; Millan, F; Revuelta, M; Romero-Ramos, M; Venero, JL | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Miele, E; Miele, M; Migheli, R; Mura, MA; Serra, P | 1 |
| Church, WH; Rappolt, G | 1 |
| Akiyama, A; Nakazato, T | 1 |
| Desole, MS; Enrico, P; Esposito, G; Miele, E; Miele, M; Migheli, R; Mura, MA; Serra, PA; Zangani, D | 1 |
| Delogu, MR; Desole, MS; Enrico, P; Esposito, G; Grella, G; Miele, E; Miele, M; Migheli, R; Mura, MA; Serra, PA | 1 |
| Delogu, MR; Desole, MS; Esposito, G; Miele, E; Miele, M; Migheli, R; Rocchitta, G; Serra, PA | 1 |
| Desole, MS; Dessanti, G; Miele, E; Miele, M; Migheli, R; Rocchitta, G; Serra, PA; Susini, G | 1 |
| He, Y; Li, X; Wu, Z; Xue, Y; Yuan, Z; Zhao, H | 1 |
| Klivényi, P; Plangár, I; Szalárdy, L; Vécsei, L; Zádori, D | 1 |
20 other study(ies) available for 3,4-dihydroxyphenylacetic acid and uric acid
| Article | Year |
|---|---|
Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Apomorphine; Ascorbic Acid; Cerebral Ventricles; Corpus Striatum; Dopamine; Dopamine Agents; Electroencephalography; Ergolines; Homovanillic Acid; Injections, Intraventricular; Kinetics; Male; Methyltyrosines; Pargyline; Pressure; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Synapses; Uric Acid | 1992 |
Neurochemical analysis of focal ischemia in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cysteine; Free Radicals; Glutathione; Guanosine; Hydroxyindoleacetic Acid; Ischemic Attack, Transient; Rats; Rats, Inbred Strains; Serotonin; Tryptophan; Uric Acid; Xanthine Oxidase | 1991 |
Further investigations into the relationship between the dopaminergic system, ascorbic acid and uric acid in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Ascorbic Acid; Body Temperature; Corpus Striatum; Dehydroascorbic Acid; Dopamine; Male; Motor Activity; Oxidation-Reduction; Pilocarpine; Rats; Rats, Inbred Strains; Scopolamine; Stereotyped Behavior; Uric Acid | 1991 |
In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Brain; Brain Chemistry; Dextroamphetamine; Dialysis; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Rats; Rats, Inbred Strains; Uric Acid | 1983 |
Interference of levodopa and its metabolites with colorimetry of uric acid.
Topics: 3,4-Dihydroxyphenylacetic Acid; Colorimetry; Dopamine; Homovanillic Acid; Humans; Levodopa; Parkinson Disease; Uric Acid | 1981 |
Fixed versus removable microdialysis probes for in vivo neurochemical analysis: implications for behavioral studies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Glutamine; Hydroxyindoleacetic Acid; Male; Microdialysis; Neuroglia; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Time Factors; Uric Acid | 1994 |
Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Glutathione; Male; MPTP Poisoning; Nerve Endings; Oxidation-Reduction; Pyridinium Compounds; Rats; Rats, Wistar; Synaptosomes; Uric Acid | 1993 |
Dopaminergic system activity and cellular defense mechanisms in the striatum and striatal synaptosomes of the rat subchronically exposed to manganese.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Ascorbic Acid; Corpus Striatum; Dehydroascorbic Acid; Dopamine; Glutathione; Male; Manganese; Neurons; Oxidative Stress; Rats; Rats, Wistar; Synaptosomes; Uric Acid | 1994 |
Effects of ageing on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxic effects on striatum and brainstem in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Antioxidants; Ascorbic Acid; Brain Stem; Corpus Striatum; Dopamine; Glutathione; Male; MPTP Poisoning; Nerve Tissue Proteins; Pyridinium Compounds; Rats; Rats, Wistar; Uric Acid | 1993 |
Effect of morphine on striatal dopamine metabolism and ascorbic and uric acid release in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Dopamine; Homovanillic Acid; Male; Microdialysis; Morphine; Narcotics; Neostriatum; Rats; Rats, Wistar; Uric Acid | 1997 |
Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Amino Acids; Animals; Ascorbic Acid Deficiency; Body Weight; Central Nervous System Diseases; Dehydroascorbic Acid; Dopamine; Dopamine Agents; Female; Guinea Pigs; Homovanillic Acid; Neostriatum; Organ Culture Techniques; Tyrosine 3-Monooxygenase; Uric Acid | 1997 |
Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Ascorbic Acid; Corpus Striatum; Dopamine; Glutamic Acid; Homovanillic Acid; Hydroxyindoleacetic Acid; Locomotion; Male; Microdialysis; Morphine; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Substantia Nigra; Uric Acid | 1998 |
Nigrostriatal catecholamine metabolism in guinea pigs is altered by purine enzyme inhibition.
Topics: 3,4-Dihydroxyphenylacetic Acid; Allopurinol; Animals; Catecholamines; Corpus Striatum; Dopamine; Enzyme Inhibitors; Guinea Pigs; Injections; Male; Norepinephrine; Oxonic Acid; Substantia Nigra; Uric Acid | 1999 |
High-speed voltammetry: dual measurement of dopamine and serotonin.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Dopamine; Dopamine Agents; Electrochemistry; Hydroxyindoleacetic Acid; Ion-Selective Electrodes; Levodopa; Male; Potentiometry; Rats; Rats, Wistar; Serotonin; Uric Acid | 1999 |
On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Dextroamphetamine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Glutamic Acid; Haloperidol; In Vitro Techniques; Injections; Male; Microdialysis; Motor Activity; Neostriatum; Oxidation-Reduction; Rats; Rats, Wistar; Stereotaxic Techniques; Stereotyped Behavior; Uric Acid | 2000 |
Manganese increases L-DOPA auto-oxidation in the striatum of the freely moving rat: potential implications to L-DOPA long-term therapy of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Chlorides; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis Solutions; Dopamine; Homovanillic Acid; Infusion Pumps; Levodopa; Male; Manganese; Manganese Compounds; Microdialysis; Movement; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Wistar; Time Factors; Uric Acid | 2000 |
A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcysteine; Animals; Ascorbic Acid; Corpus Striatum; Deferoxamine; Dialysis Solutions; Dopamine; Dose-Response Relationship, Drug; Free Radical Scavengers; Homovanillic Acid; Iron; Male; Metalloporphyrins; Molsidomine; Movement; Nitric Oxide; Nitric Oxide Donors; Rats; Rats, Wistar; Uric Acid | 2001 |
Effects of sufentanil on the release and metabolism of dopamine and ascorbic acid and glutamate release in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Ascorbic Acid; Corpus Striatum; Dopamine; Glutamic Acid; Homovanillic Acid; Injections, Intraperitoneal; Injections, Intraventricular; Male; Microdialysis; Movement; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar; Sufentanil; Uric Acid | 2003 |
Simultaneous determination of 3,4-dihydroxyphenylacetic acid, uric acid and ascorbic acid by poly(L-arginine)/multi-walled carbon nanotubes composite film.
Topics: 3,4-Dihydroxyphenylacetic Acid; Ascorbic Acid; Nanocomposites; Nanotechnology; Nanotubes, Carbon; Oxidation-Reduction; Peptides; Uric Acid | 2011 |
Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Allopurinol; Animals; Brain; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Drug Administration Schedule; Flavanones; Homovanillic Acid; Infusions, Parenteral; Male; Mice; Mice, Inbred C57BL; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neurotoxins; Oxidative Stress; Parkinson Disease; Silymarin; Sulfinpyrazone; Uric Acid | 2013 |